A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PDE5

Search Conditions:
Search Keyword : PDE5
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: PDE5
Appearance Frequency: 1372 time(s)
Long forms: 19

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
phosphodiesterase type 5
(1293 times)
Urology
(296 times)
ED (326 times)
NO (175 times)
cGMP (167 times)
1996 Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
phosphodiesterase-5 inhibitor
(28 times)
Urology
(8 times)
ED (10 times)
BPH (3 times)
HPCD (2 times)
2007 [Sexual activity and cardiovascular risk].
phosphodiesterase type 5 inhibitors
(22 times)
Urology
(18 times)
ED (10 times)
IIEF (4 times)
EF (3 times)
2002 Selective phosphodiesterase type 5 inhibition using tadalafil for the treatment of erectile dysfunction.
Phosphodiesterase type 5 enzyme
(6 times)
Chemistry
(2 times)
ACE (1 time)
CVOD (1 time)
ED (1 time)
2006 Reverse fingerprinting, similarity searching by group fusion and fingerprint bit importance.
PDE type 5
(4 times)
Cardiology
(2 times)
PDE (2 times)
ANP (1 time)
cAMP (1 time)
2007 Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Protective effect of phosphodiesterase 5
(4 times)
Urology
(2 times)
ATP (1 time)
BUN (1 time)
CCK-8 (1 time)
2008 Oral phosphodiesterase-5 inhibitors and sperm functions.
phosphodiesterase inhibitor type 5
(2 times)
Infant, Newborn, Diseases
(1 time)
DRAQ (1 time)
ED (1 time)
iNO (1 time)
2012 Is sildenafil an effective therapy in the management of persistent pulmonary hypertension?
Phosphodiesterase type 5 inhibitors
(2 times)
Sexual Dysfunction, Physiological
(2 times)
ED (1 time)
2010 Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms?
1-(2-Ethoxyethyl)-1H-pyrazolo(4,3-d)pyrimidines as potent phosphodiesterase 5
(1 time)
Biochemistry
(1 time)
--- 2010 1-(2-Ethoxyethyl)-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors.
10  cGMP-Phosphodiesterase type 5
(1 time)
Chemistry
(1 time)
--- 2008 Structure -activity relationships of PDE5 inhibitors.
11  pain, erectile dysfunction, phosphodiesterase-5
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
SSRIs (1 time)
2005 Pharmacological treatment for premature ejaculation.
12  PDE isoenzyme 5
(1 time)
Chemistry
(1 time)
PDE (1 time)
2007 The role of PDE5-inhibitors in cardiopulmonary disorders: from basic evidence to clinical development.
13  PDE5-TG
(1 time)
Cardiology
(1 time)
LV (1 time)
2009 Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice.
14  phosfodiesterasis-5
(1 time)
General Surgery
(1 time)
APA (1 time)
SD (1 time)
2009 [Sexual dysfunction in men after surgery of colorectal carcinoma. New developments in prevention and therapy].
15  Phosphodiesterase enzyme type 5
(1 time)
Psychopharmacology
(1 time)
AChE (1 time)
2005 Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation.
16  preclinical data demonstrating that phosphodiesterase-5
(1 time)
Neoplasms
(1 time)
HNSCC (1 time)
MDSC (1 time)
2015 Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.
17  previously demonstrated that phosphodiesterase-5
(1 time)
Cardiology
(1 time)
cGMP (1 time)
ET (1 time)
NO (1 time)
2014 Phosphodiesterase-5 activity exerts a coronary vasoconstrictor influence in awake swine that is mediated in part via an increase in endothelin production.
18  prostaglandin type-5
(1 time)
Urology
(1 time)
ED (1 time)
RP (1 time)
SNG (1 time)
2009 Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer.
19  protein expresion of phosphodiesterase5
(1 time)
Genetics, Medical
(1 time)
AD (1 time)
NF-kappaB (1 time)
PPAR (1 time)
2016 Neuroprotective effects of sodium hydrosulfide against beta-amyloid-induced neurotoxicity.